Sourinejad Hadis, Shayan Arezoo, Niyati Shiva, Moghaddam-Banaem Lida
Department of Reproductive Health and Midwifery, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran.
Departmnt of Midwifery, Fauclty Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran.
Med J Islam Repub Iran. 2019 Dec 23;33:147. doi: 10.34171/mjiri.33.147. eCollection 2019.
The prevalence of metabolic syndrome has been rising worldwide in recent decades. Determining the associations between metabolic syndrome and its components in midpregnancy with neonatal anthropometric indices and outcomes is a major challenge in both public health and clinical care. This prospective cohort study was performed on 238 pregnant women at 24-28 weeks of gestation. Metabolic syndrome was recognized with 3 or more of the following criteria: triglyceride ≥ 247 mg/dL; HDL < 61 mg/dL; GCT ≥ 140 mg/dL; prepregnancy body mass index ≥ 30 kg/m2; and blood pressure ≥ 130/85 mmHg. Statistical analysis was performed through descriptive statistics, including mean, standard deviation, frequency, and percentage, Mann-Whitney test, Chi-square test, Fisher's exact test, linear and logistic regression in SPSS 21.0. P values < 0.05 were considered significant. There was a significant association between blood hypertriglyceridemia in weeks 24-28 and anthropometric indices, including weight, height, and jaundice, in the first 24 hours of birth. Metabolic syndrome also had a significant relationship with jaundice (P=0.002). The results of linear regression analysis revealed that metabolic syndrome was positively associated with birth weight (B=0.18, P=0.003) and height (B=0.18, P=0.009). Among the components of metabolic syndrome, the results showed a direct relationship between increased blood triglyceride of the mother and newborn's weight (B=0.11, P=0.011) and height (B=0.14, P=0.007). Also, increased BMI had a significant direct relationship with the newborn's weight (B=0.11, P=0.023) and height (B=0.12, P=0.023). Moreover, decreased HDL had a significant reverse relationship with the newborn's weight (B=0.09, P=0.042). Presence of metabolic syndrome and its components in midpregnancy may influence neonatal outcomes, especially anthropometric indices. However, more studies should be conducted to further investigate these relationships.
近几十年来,代谢综合征在全球范围内的患病率一直在上升。确定孕中期代谢综合征及其各组分与新生儿人体测量指标和结局之间的关联,是公共卫生和临床护理领域面临的一项重大挑战。这项前瞻性队列研究对238名妊娠24 - 28周的孕妇进行。代谢综合征通过以下3项或更多标准来识别:甘油三酯≥247mg/dL;高密度脂蛋白<61mg/dL;葡萄糖耐量试验≥140mg/dL;孕前体重指数≥30kg/m²;血压≥130/85mmHg。通过描述性统计进行统计分析,包括均值、标准差、频数和百分比,采用曼 - 惠特尼检验、卡方检验、费舍尔精确检验,以及在SPSS 21.0中进行线性和逻辑回归分析。P值<0.05被认为具有统计学意义。孕24 - 28周时的高甘油三酯血症与出生后最初24小时内的人体测量指标,包括体重、身高和黄疸,之间存在显著关联。代谢综合征与黄疸也有显著关系(P = 0.002)。线性回归分析结果显示,代谢综合征与出生体重呈正相关(B = 0.18,P = 0.003)和身高呈正相关(B = 0.18,P = 0.009)。在代谢综合征的各组分中,结果显示母亲血液甘油三酯升高与新生儿体重(B = 0.11,P = 0.011)和身高(B = 0.14,P = 0.007)之间存在直接关系。此外,体重指数升高与新生儿体重(B = 0.11,P = 0.023)和身高(B = 0.12,P = 0.023)有显著直接关系。而且,高密度脂蛋白降低与新生儿体重有显著负相关(B = 0.09,P = 0.042)。孕中期代谢综合征及其组分的存在可能会影响新生儿结局,尤其是人体测量指标。然而,需要开展更多研究以进一步探究这些关系。